US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.7600
  • -0.1100-5.88%
Close Dec 18 16:00 ET
  • 1.8000
  • +0.0400+2.27%
Pre 08:35 ET
384.00MMarket Cap-8.00P/E (TTM)

Akebia Therapeutics Key Stats

Akebia Therapeutics Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
44.51M
37.43M
-7.08M
Miss Est.
+5.85%
-10.98%
-15.90%
EPS
-0.06
-0.10
-0.04
Miss Est.
+20.90%
-25.00%
-58.23%
Strong Buy

Nov 30, 2024

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 35.614M--
--2024/Q4-- / 40.912M--
Nov 7, 20242024/Q337.428M / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
May 9, 20242024/Q132.607M / 46.087M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 35.614M--
--2024/Q4-- / 40.912M--
Nov 7, 20242024/Q337.428M / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
May 9, 20242024/Q132.607M / 46.087M--

Unlock Free Earnings Estimates

Akebia Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data